Amphenol Reports Record Q4 & Full-Year 2025 Results, Exceeding Guidance with Strong Q1 2026 Outlook
Summary
Amphenol reported record Q4 and full-year 2025 financial results, exceeding guidance, driven by strong organic growth and successful acquisitions, and provided a robust outlook for Q1 2026.
Key Events
-
Record Financial Performance
Achieved record sales of $6.4 billion in Q4 2025 (up 49%) and $23.1 billion for the full year (up 52%), both significantly exceeding guidance.
-
Strong Profitability & Cash Flow
Reported Q4 Adjusted Diluted EPS of $0.97 (up 76%) and full-year Adjusted Diluted EPS of $3.34 (up 77%), alongside robust operating and free cash flow.
-
Optimistic Q1 2026 Guidance
Forecasts Q1 2026 sales of $6.90-$7.00 billion (up 43-45%) and Adjusted Diluted EPS of $0.91-$0.93 (up 44-48%), including accretion from the CommScope CCS acquisition.
-
Strategic Acquisitions & Shareholder Returns
Completed five acquisitions in 2025, including Trexon, and returned nearly $1.5 billion to shareholders through buybacks and dividends.
Analysis
Amphenol Corporation delivered exceptional financial performance for the fourth quarter and full year 2025, surpassing its own guidance with record sales and adjusted diluted EPS. The company demonstrated robust organic growth across its end markets, particularly in IT datacom, and successfully integrated multiple acquisitions. The positive momentum is projected to continue into the first quarter of 2026 with strong guidance, including contributions from the recently closed CommScope CCS acquisition. While a $100 million accrual for a tax challenge in China presents a minor headwind, the overall operational strength and optimistic outlook reinforce a strong investment thesis.
At the time of this filing, APH was trading at $145.24 on NYSE in the Manufacturing sector, with a market capitalization of approximately $203.5B. The 52-week trading range was $56.45 to $167.04. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.